Exercise and Diet for Metabolic Disorders
(MsFIT Trial)
Trial Summary
What is the purpose of this trial?
This study aims to produce new evidence, specific to women, on the efficacy and mechanisms of exercise and diet for cardiometabolic risk reduction in pre and postmenopausal women. Using a 3-arm randomized controlled trial (RCT) with equal recruitment and stratification by menopausal status to 6 months of: 1) exercise following Health Canada guidelines; 2) the same exercise plus counselling to follow Canada's Dietary Guidelines to improve diet quality; or 3) stretching group, this study will answer the following questions: * How does the impact of exercise compare among each of the causal links between physical inactivity and cardiometabolic disease in women? * What is the effect modification of adding a diet quality intervention to exercise? * What is the effect modification by menopausal status? The investigators hypothesize that exercise adaptations will be: 1) largest peripherally, including Matsuda index (primary outcome), Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), arteriovenous oxygen difference (avO2diff), and visceral fat, compared to centrally (stroke volume (SV), endothelial function, aortic stiffness), 2) blunted or absent in post vs premenopause; 3) enhanced by the addition of diet quality which will be essential or additive for Matsuda index, metabolic syndrome, Framingham cardiovascular disease (CVD) risk, cytokines and adipokines, thigh myosteatosis, muscle mass, peak oxygen uptake (VO2peak), 4) enhanced by adding diet quality in more outcomes postmenopause.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking weight loss medications, you may not be eligible to participate.
What data supports the effectiveness of the treatment involving exercise and diet for metabolic disorders?
Research shows that following Canada's physical activity guidelines can significantly reduce the risk of chronic diseases like heart disease, type 2 diabetes, and hypertension. Regular physical activity, as recommended, is linked to lower rates of these conditions and can help prevent premature death.12345
Is the exercise and diet treatment generally safe for humans?
How does the treatment 'Exercise and Diet for Metabolic Disorders' differ from other treatments for metabolic disorders?
This treatment is unique because it combines guidelines-based physical activity and healthy eating, following Health Canada guidelines, to address metabolic disorders. Unlike medications, it focuses on lifestyle changes that can prevent and manage a wide range of chronic conditions, such as heart disease and diabetes, by promoting moderate-intensity exercise and a balanced diet.12348
Research Team
Amy A Kirkham, PhD
Principal Investigator
University of Toronto
Eligibility Criteria
This trial is for pre and postmenopausal women who are dealing with metabolic disorders due to a sedentary lifestyle. Participants should be interested in improving their health through physical activity and possibly dietary changes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to one of three groups: exercise following Health Canada guidelines, exercise plus dietary counseling, or a stretching group for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Guidelines-based physical activity
- Guidelines-based physical activity and healthy eating
- Stretching exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator